{"id":"W4367047605","doi":"10.1001/jamanetworkopen.2023.10039","title":"Safety and Efficacy of Combined Tixagevimab and Cilgavimab Administered Intramuscularly or Intravenously in Nonhospitalized Patients With COVID-19","year":2023,"lang":"en","type":"article","venue":"JAMA Network Open","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada)","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health; National Center for Advancing Translational Sciences; AstraZeneca","keywords":"Coronavirus disease 2019 (COVID-19); Medicine; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Virology; Internal medicine; Outbreak","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001928913,0.0006676959,0.001681346,0.0002286039,0.0002274642,0.0007277427,0.0004953839,0.001181318,0.002546316],"category_scores_gemma":[0.003481803,0.0003789486,0.001073799,0.0002643472,0.0005621155,0.0005733193,0.0002469156,0.001456403,0.000391083],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000606758,"about_ca_system_score_gemma":0.0008958388,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003770656,"about_ca_topic_score_gemma":0.0005454365,"domain_scores_codex":[0.9987562,0.0007695845,0.00008034128,0.0001724722,0.0001265243,0.00009487449],"domain_scores_gemma":[0.9981969,0.0005090155,0.0007902643,0.0001082017,0.000112862,0.0002829042],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8954749,0.00935784,0.01584146,0.0007149533,0.001580657,0.0000859736,0.00009894321,0.0005795035,0.009059391,0.00009448874,0.001038087,0.06607385],"study_design_scores_gemma":[0.4099233,0.539986,0.04184882,0.0001226347,0.001334311,0.0001917961,0.0000841572,0.001372971,0.003425157,0.0001361528,0.001541057,0.00003366276],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9932293,0.004323506,0.0003777597,0.0002343958,0.00009790724,0.0005213709,0.0003281189,0.00003234639,0.0008552467],"genre_scores_gemma":[0.9977054,0.0005668903,0.0004017153,0.0001914384,0.0001431766,0.0005375948,0.0002164898,0.000004517782,0.0002327304],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002546316,"threshold_uncertainty_score":0.01020116,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03367806491160733,"score_gpt":0.3402387068771673,"score_spread":0.3065606419655599,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}